首页> 外文期刊>Diabetes >lnterleukin-6 Reduces p-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response
【24h】

lnterleukin-6 Reduces p-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response

机译:Interleukin-6通过将自噬与抗氧化反应联系起来降低p细胞氧化应激

获取原文
获取原文并翻译 | 示例
       

摘要

Production of reactive oxygen species (ROS) is a key instigator of β-cell dysfunction in diabetes. The pleiotro-pic cytokine interleukin 6 (IL-6) has previously been linked to β-cell autophagy but has not been studied in the context of (i-cell antioxidant response. We used a combination of animal models of diabetes and analysis of cultured human islets and rodent p-cells to study how IL-6 influences antioxidant response. We show that IL-6 couples autophagy to antioxidant response and thereby reduces ROS in |i-cells and human islets. P-Cell-specific loss of IL-6 signaling in vivo renders mice more susceptible to oxidative damage and cell death through the selective [i-cell toxins streptozotocin and alloxan. IL-6-driven ROS reduction is associated with an increase in the master antioxidant factor NRF2, which rapidly translocates to the mitochondria to decrease mltochondrial activity and stimulate mitophagy. IL-6 also initiates a robust transient decrease in cellular cAMP levels, likely contributing to the stimulation of mitophagy to mitigate ROS. Our findings suggest that coupling autophagy to antioxidant response in β-cells leads to stress adaptation that can reduce cellular apoptosis. These findings have implications for β-cell survival under diabetogenic conditions and present novel targets for therapeutic intervention.
机译:活性氧(ROS)的产生是糖尿病患者β细胞功能异常的关键诱因。多效性细胞因子白介素6(IL-6)以前与β细胞自噬有关,但尚未在(i细胞抗氧化剂反应的情况下)进行过研究。我们结合了糖尿病动物模型和培养物分析人类胰岛和啮齿动物p细胞,研究IL-6如何影响抗氧化反应,我们证明IL-6将自噬与抗氧化反应结合,从而降低了i细胞和人类胰岛中的ROS。体内的6种信号转导使小鼠更易受到选择性[i-细胞毒素链脲佐菌素和四氧嘧啶的氧化损伤和细胞死亡的影响。IL-6驱动的ROS减少与主要抗氧化剂因子NRF2的增加有关,后者迅速转移到小鼠体内。线粒体可降低线粒体活性并刺激线粒体,IL-6还可引起细胞内cAMP水平的短暂瞬时降低,可能有助于线粒体的刺激以减轻ROS。对β细胞中抗氧化剂反应的厌恶会导致压力适应,从而减少细胞凋亡。这些发现对在糖尿病形成条件下β细胞存活具有影响,并提出了治疗干预的新靶标。

著录项

  • 来源
    《Diabetes》 |2018年第8期|1576-1588|共13页
  • 作者单位

    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;

    Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN;

    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;

    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;

    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN;

    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN,Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN,Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN,Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN;

    Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN,Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN,Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN,Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:02

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号